|
EWTX Edgewise Therapeutics Inc 1710072 |
| Balance Sheet |
|
Current Assets
|
475,483,000 |
|
Assets
|
486,817,000 |
|
Current Liabilities
|
23,860,000 |
|
Liabilities
|
27,601,000 |
|
Equity
|
459,216,000 |
|
Shares Out
|
93,772,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-109,028,000 |
|
Investing Cash Flow
|
-184,656,000 |
| Market Analysis |
Market Cap
|
1,769,482,813 |
|
Price
|
24.13 |
|
BVPS
|
4.90 |
|
PB
|
4.82 |
|
EPS
|
-1.53 |
|
PS
|
0.46 |
|
FCF
|
-293,684,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/22 |
-0.47 |
3/3 |
-1.45 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EWTX documents filed with the SEC.
EWTX Filings
Clear
